课题基金 / 基金详情

CLINICAL TRIAL: PHASE III, ICA-17043 WITH OR WITHOUT HYDROXYUREA IN SICKLE CELL

CLINICAL TRIAL: PHASE III, ICA-17043 WITH OR WITHOUT HYDROXYUREA IN SICKLE CELL
临床试验：III 期，ICA-17043 在镰状细胞中含或不含羟基脲
批准号：
7716822
负责人：
Kenneth I Ataga
金额：
$0.14万
依托单位：
UNIV OF NORTH CAROLINA CHAPEL HILL
依托单位国家：
美国
项目类别：
财政年份：
2008
资助国家：
美国
项目状态：
已结题
起止时间：
2008-04-02 至 2008-05-31
来源：
https://reporter.nih.gov/project-details/7716822
关键词：
Computer Retrieval of Information on Scientific Projects DatabaseEffectivenessFundingGrantInstitutionPainPatientsPharmaceutical PreparationsPhase III Clinical TrialsPurposeResearchResearch PersonnelResourcesSafetySickle CellSourceUnited States National Institutes of Healthhydroxyurearesearch study

项目摘要

项目成果

Kenneth I Ataga的其他基金

相似基金

相关文献

中文摘要
翻译
该子项目是利用 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得主要资金， 因此可以在其他CRISP条目中表示。列出的机构是 中心，不一定是研究者的机构。 这项研究的目的是确定名为伊卡-17043的实验性药物在每年有两次或两次以上疼痛危机的镰状细胞患者中的安全性和有效性。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this research study is to determine the safety and effectiveness of the experimental drug called ICA-17043 in sickle cell patients who have two or more pain crises per year.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Predicting Progression of Chronic Kidney Disease in Sickle Cell Anemia Using Machine Learning Models (PREMIER)
Predicting Progression of Chronic Kidney Disease in Sickle Cell Anemia Using Machine Learning Models (PREMIER)
THE ASSOCIATION OF BIOMARKERS OF ENDOTHELIAL FUNCTION WITH PROSPECTIVE CHANGES IN KIDNEY FUNCTION IN SICKLE CELL ANEMIA
THE ASSOCIATION OF BIOMARKERS OF ENDOTHELIAL FUNCTION WITH PROSPECTIVE CHANGES IN KIDNEY FUNCTION IN SICKLE CELL ANEMIA
海外基金